{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:06:49Z","timestamp":1793869609105,"version":"4.6.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2458-14-1320","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T07:18:31Z","timestamp":1434611911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Specific genotypes of human papillomavirus in 125 high-grade squamous lesions and invasive cervical cancer cases from Congolese women"],"prefix":"10.1186","volume":"14","author":[{"given":"Luc Magloire Anicet","family":"Boumba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lahoucine","family":"Hilali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Mouallif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatien","family":"Moukassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moulay Mustapha","family":"Ennaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,23]]},"reference":[{"key":"7551_CR1","volume-title":"GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. 2013, Lyon, France: International Agency for Research on Cancer, Available from http:\/\/globocan.iarc.fr"},{"issue":"Suppl 5","key":"7551_CR2","doi-asserted-by":"publisher","first-page":"F32","DOI":"10.1016\/j.vaccine.2012.07.092","volume":"31","author":"H De Vuyst","year":"2013","unstructured":"De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, et al: The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine. 2013, 31 (Suppl 5): F32-46.","journal-title":"Vaccine"},{"issue":"12","key":"7551_CR3","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Canc. 2010, 127 (12): 2893-2917. 10.1002\/ijc.25516.","journal-title":"Int J Canc"},{"key":"7551_CR4","volume-title":"information centre on HPV and cervical cancer (HPV information center). Human Papillomavirus and related Deseases in Congo.","author":"WHO\/ICO","year":"2014","unstructured":"WHO\/ICO: Summary Report [17 june 2014]. information centre on HPV and cervical cancer (HPV information center). Human Papillomavirus and related Deseases in Congo. 2014, http:\/\/www.hpvcentre.net\/statistics\/reports\/COG.pdf,"},{"key":"7551_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-19. 10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.","journal-title":"J Pathol"},{"key":"7551_CR6","first-page":"261","volume-title":"Human Papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100: A Review of Human Carcinogens - Part B: Biological Agents","author":"IARC","year":"2011","unstructured":"IARC: Human Papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100: A Review of Human Carcinogens - Part B: Biological Agents. 2011, 261-319."},{"key":"7551_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/djq540","volume":"103","author":"M Schiffman","year":"2011","unstructured":"Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE: Human Papillomavirus Testing in the Prevention of Cervical Cancer. J Natl Cancer Inst. 2011, 103: 1-16.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"7551_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","volume":"10","author":"V Bouvard","year":"2009","unstructured":"Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al: A review of human carcinogens-Part B: biological agents. Lancet Oncol. 2009, 10 (4): 321-322. 10.1016\/S1470-2045(09)70096-8.","journal-title":"Lancet Oncol"},{"issue":"7","key":"7551_CR9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJM199802123380703","volume":"338","author":"GYF Ho","year":"1998","unstructured":"Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD: Natural History of Cervicovaginal Papillomavirus Infection in Young Women. New England Journal of Medicine. 1998, 338 (7): 423-428. 10.1056\/NEJM199802123380703.","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"7551_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/jnci\/djq001","volume":"102","author":"AC Rodr\u00edguez","year":"2010","unstructured":"Rodr\u00edguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, et al: Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2\/3: Critical Role of Duration of Infection. Journal of the National Cancer Institute. 2010, 102 (5): 315-324. 10.1093\/jnci\/djq001. Available from http:\/\/jnci.oxfordjournals.org\/content\/102\/5\/315.abstract.","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"7551_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1552-6909.2008.00304.x","volume":"38","author":"AM Teitelman","year":"2009","unstructured":"Teitelman AM, Stringer M, Averbuch T, Witkoski A: Human papillomavirus, current vaccines, and cervical cancer prevention. Journal of obstetric, gynecologic, and neonatal nursing : JOGNN \/ NAACOG. 2009, 38 (1): 69-80. 10.1111\/j.1552-6909.2008.00304.x.","journal-title":"Journal of obstetric, gynecologic, and neonatal nursing : JOGNN \/ NAACOG"},{"issue":"9518","key":"7551_CR12","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","volume":"367","author":"DM Harper","year":"2006","unstructured":"Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al: Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006, 367 (9518): 1247-1255. 10.1016\/S0140-6736(06)68439-0.","journal-title":"Lancet"},{"issue":"5","key":"7551_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/OGX.0b013e31819f992e","volume":"64","author":"J Bornstein","year":"2009","unstructured":"Bornstein J: The HPV vaccines\u2013which to prefer?. Obstetrical & gynecological survey. 2009, 64 (5): 345-350. 10.1097\/OGX.0b013e31819f992e.","journal-title":"Obstetrical & gynecological survey"},{"issue":"9580","key":"7551_CR14","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","volume":"369","author":"J Paavonen","year":"2007","unstructured":"Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM, et al: Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007, 369 (9580): 2161-2170. 10.1016\/S0140-6736(07)60946-5.","journal-title":"Lancet"},{"issue":"3","key":"7551_CR15","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1086\/653826","volume":"202","author":"K Louvanto","year":"2010","unstructured":"Louvanto K, Rintala MA, Syrj\u00e4nen KJ, Gr\u00e9nman SE, Syrj\u00e4nen SM: Genotype-Specific Persistence of Genital Human Papillomavirus (HPV) Infections in Women Followed for 6 Years in the Finnish Family HPV Study. Journal of Infectious Diseases. 2010, 202 (3): 436-444. 10.1086\/653826.","journal-title":"Journal of Infectious Diseases"},{"issue":"11","key":"7551_CR16","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WGV, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al: Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. The Lancet Oncology. 2010, 11 (11): 1048-1056. 10.1016\/S1470-2045(10)70230-8. Available from http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1470204510702308. DOI http:\/\/dx.doi.org\/10.1016\/S1470-2045(10)70230-8.","journal-title":"The Lancet Oncology"},{"issue":"4","key":"7551_CR17","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ijc.25396","volume":"128","author":"N Li","year":"2011","unstructured":"Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM: Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer. 2011, 128 (4): 927-935. 10.1002\/ijc.25396.","journal-title":"Int J Cancer"},{"issue":"18","key":"7551_CR18","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/jnci\/82.18.1477","volume":"82","author":"RM Resnick","year":"1990","unstructured":"Resnick RM, Cornelissen MT, Wright DK, Eichinger GH, Fox HS, ter Schegget J, et al: Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst. 1990, 82 (18): 1477-1484. 10.1093\/jnci\/82.18.1477.","journal-title":"J Natl Cancer Inst"},{"key":"7551_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1472-6890-9-3","volume":"9","author":"SH Lee","year":"2009","unstructured":"Lee SH, Vigliotti VS, Vigliotti JS, Pappu S: Validation of human papillomavirus genotyping by signature DNA sequence analysis. BMC Clin Pathol. 2009, 9: 3-10.1186\/1472-6890-9-3.","journal-title":"BMC Clin Pathol"},{"key":"7551_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/jnci\/djj067","volume":"98","author":"X Castellsague","year":"2006","unstructured":"Castellsague X, Diaz M, de Sanjose S, Munoz N, Herrero R, Franceschi S, et al: Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst. 2006, 98: 303-315. 10.1093\/jnci\/djj067.","journal-title":"J Natl Cancer Inst"},{"key":"7551_CR21","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/ijc.23292","volume":"122","author":"X Castellsague","year":"2008","unstructured":"Castellsague X, Klaustermeier J, Carrilho C, Albero G, Sacarlal J, Quint W, et al: Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: Burden and potential for prevention. Int J Cancer. 2008, 122: 1901-1904.","journal-title":"Int J Cancer"},{"issue":"10","key":"7551_CR22","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1111\/j.1365-3156.2009.02372.x","volume":"14","author":"KS Louie","year":"2009","unstructured":"Louie KS, de Sanjose S, Mayaud P: Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Tropical medicine & international health : TM & IH. 2009, 14 (10): 1287-1302. 10.1111\/j.1365-3156.2009.02372.x.","journal-title":"Tropical medicine & international health : TM & IH"},{"issue":"1","key":"7551_CR23","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/1743-422X-8-514","volume":"8","author":"F Piras","year":"2011","unstructured":"Piras F, Piga M, De Montis A, Zannou A, Minerba L, Perra M, et al: Prevalence of human papillomavirus infection in women in Benin. West Africa. Virology Journal. 2011, 8 (1): 514-Available from http:\/\/www.virologyj.com\/content\/8\/1\/514.","journal-title":"West Africa. Virology Journal"},{"key":"7551_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/1471-2407-13-357","volume":"13","author":"CM de Oliveira","year":"2013","unstructured":"de Oliveira CM, Fregnani JH, Carvalho JP, Longatto-Filho A, Levi JE: Human papillomavirus genotypes distribution in 175 invasive cervical cancer cases from Brazil. BMC Cancer. 2013, 13: 357-10.1186\/1471-2407-13-357.","journal-title":"BMC Cancer"},{"issue":"1","key":"7551_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1750-9378-7-26","volume":"7","author":"P Giorgi Rossi","year":"2012","unstructured":"Giorgi Rossi P, Sideri M, Carozzi FM, Vocaturo A, Buonaguro FM, Tornesello ML, et al: HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies. Infectious Agents and Cancer. 2012, 7 (1): 26-10.1186\/1750-9378-7-26.","journal-title":"Infectious Agents and Cancer"},{"issue":"6","key":"7551_CR26","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/IGC.0b013e318259d904","volume":"22","author":"T Chinchai","year":"2012","unstructured":"Chinchai T, Chansaenroj J, Swangvaree S, Junyangdikul P, Poovorawan Y: Prevalence of human papillomavirus genotypes in cervical cancer. Int J Gynecol Cancer. 2012, 22 (6): 1063-1068. 10.1097\/IGC.0b013e318259d904.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"7551_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1750-9378-7-34","volume":"7","author":"R Peralta-Rodriguez","year":"2012","unstructured":"Peralta-Rodriguez R, Romero-Morelos P, Villegas-Ruiz V, Mendoza-Rodriguez M, Taniguchi-Ponciano K, Gonzalez-Yebra B, et al: Prevalence of human papillomavirus in the cervical epithelium of Mexican women: meta-analysis. Infectious Agents and Cancer. 2012, 7 (1): 34-10.1186\/1750-9378-7-34.","journal-title":"Infectious Agents and Cancer"},{"issue":"1","key":"7551_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1750-9378-8-20","volume":"8","author":"M Haghshenas","year":"2013","unstructured":"Haghshenas M, Golini-moghaddam T, Rafiei A, Emadeian O, Shykhpour A, Ashrafi GH: Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: a population-based study. Infectious Agents and Cancer. 2013, 8 (1): 20-10.1186\/1750-9378-8-20.","journal-title":"Infectious Agents and Cancer"},{"key":"7551_CR29","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/jnci\/dji187","volume":"97","author":"MJ Khan","year":"2005","unstructured":"Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, et al: The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005, 97: 1072-1079. 10.1093\/jnci\/dji187.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"7551_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jviromet.2006.02.007","volume":"135","author":"MP Stevens","year":"2006","unstructured":"Stevens MP, Garland SM, Tabrizi SN: Human papillomavirus genotyping using a modified linear array detection protocol. J Virol Methods. 2006, 135 (1): 124-126. 10.1016\/j.jviromet.2006.02.007.","journal-title":"J Virol Methods"},{"issue":"3","key":"7551_CR31","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/sj.bjc.6601515","volume":"90","author":"JO Thomas","year":"2004","unstructured":"Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, et al: Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer. 2004, 90 (3): 638-645. 10.1038\/sj.bjc.6601515.","journal-title":"Br J Cancer"},{"issue":"1","key":"7551_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1746-1596-4-31","volume":"4","author":"B Garcia-Espinosa","year":"2009","unstructured":"Garcia-Espinosa B, Nieto-Bona MP, Rueda S, Silva-Sanchez L, Piernas-Morales MC, Carro-Campos P, et al: Genotype distribution of cervical human papillomavirus DNA in women with cervical lesions in Bioko. Equatorial Guinea. Diagnostic Pathology. 2009, 4 (1): 31-10.1186\/1746-1596-4-31.","journal-title":"Equatorial Guinea. Diagnostic Pathology"},{"issue":"3","key":"7551_CR33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ijc.22527","volume":"121","author":"JS Smith","year":"2007","unstructured":"Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007, 121 (3): 621-632. 10.1002\/ijc.22527.","journal-title":"Int J Cancer"},{"issue":"1","key":"7551_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","volume":"88","author":"GM Clifford","year":"2003","unstructured":"Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003, 88 (1): 63-73. 10.1038\/sj.bjc.6600688.","journal-title":"Br J Cancer"},{"issue":"2","key":"7551_CR35","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jcv.2013.02.010","volume":"57","author":"EK Alidjinou","year":"2013","unstructured":"Alidjinou EK, Ebatetou-Ataboho E, Sane F, Moukassa D, Dewilde A, Hober D: Cervical samples dried on filter paper and dried vaginal tampons can be useful to investigate the circulation of high-risk HPV in Congo. J Clin Virol. 2013, 57 (2): 161-164. 10.1016\/j.jcv.2013.02.010.","journal-title":"J Clin Virol"},{"key":"7551_CR36","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/1471-2334-10-214","volume":"10","author":"P Giorgi Rossi","year":"2010","unstructured":"Giorgi Rossi P, Bisanzi S, Paganini I, Di Iasi A, Angeloni C, Scalisi A, et al: Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study. BMC Infect Dis. 2010, 10: 214-","journal-title":"BMC Infect Dis"},{"issue":"1","key":"7551_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1750-9378-5-24","volume":"5","author":"C Okolo","year":"2010","unstructured":"Okolo C, Franceschi S, Adewole I, Thomas J, Follen M, Snijders P, et al: Human papillomavirus infection in women with and without cervical cancer in Ibadan. Nigeria. Infectious Agents and Cancer. 2010, 5 (1): 24-10.1186\/1750-9378-5-24.","journal-title":"Nigeria. Infectious Agents and Cancer"},{"key":"7551_CR38","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ijid.2006.06.007","volume":"11","author":"S Khan","year":"2007","unstructured":"Khan S, Jaffer NN, Khan MN, Rai MA, Shafiq M, Ali A, et al: Human papillomavirus subtype 16 is common in Pakistaniwomen with cervical carcinoma. Int J Infect Dis. 2007, 11: 313-317. 10.1016\/j.ijid.2006.06.007.","journal-title":"Int J Infect Dis"},{"key":"7551_CR39","volume-title":"Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in World.","author":"WHO\/ICO","year":"2010","unstructured":"WHO\/ICO: Summary Report 2010 [accessed on 2014-05-09]. Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in World. 2010"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-14-1320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-14-1320\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-14-1320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-14-1320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T15:17:59Z","timestamp":1691767079000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-14-1320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["7551"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-14-1320","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"9 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"1320"}}